Skip to content

← All news

Markets

Inhibrx Biosciences director Jon Kayyem buys $500,000 in common stock

1 source ·1 article ·Sep 23, 21:32 UTC Inhibrx Biosciences

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·Sep 23, 21:32 UTC

Inhibrx Biosciences director Jon Kayyem buys $500,000 in common stock